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Background: The current definition of acute myocardial infarction requires the presence of serum biomarkers as the central criteria. The 
recommended biomarkers due to their high specificity are the troponins. The role of measuring CK-MB in this context is of uncertain significance.
Methods: A retrospective study of patients presenting to the VA medical center in Phoenix, AZ, during the years 2000-2003 with a diagnosis of 
NSTE-ACS. The patients were divided into 4 groups on the basis of marker positivity and mortality data for all the groups for up to 5 years was 
assessed.
Results: Total of 8,654 patients met inclusion criteria. A regression analysis revealed that for patients CK-MB +/Trop +, HR 1.21 (95% CI 1.50-
1.95) compared with patients with both markers negative. The similar ratios for patients in groups CK-MB +/Trop - and CK-MB - /Trop + were 
HR1.24 (95% CI 1.10-1.40) and HR0.99 (95% CI 0.84-1.0) respectively. There was no significant difference in age, gender, major comorbidities (eg. 
CKD, DM, CHF) and the use of drugs (eg. statin, ACE-I, digoxin) between the groups. Patients with elevated CK-MB had higher mortality regardless of 
troponin status. A Kaplan Meier survival curve is displayed:
Conclusions: CK-MB was found to have prognostic value independent of troponins, the prognosis of patients with elevation of CK-MB was worse 
than patients with troponin elevation. Based upon these results, the measurement of CK-MB might still have a role and should not be discarded in 
the current era of troponins.
